B. Riley Securities Maintains Buy on LuxExperience, Raises Price Target to $13
B. Riley Securities analyst Anna Glaessgen maintains LuxExperience (NYSE:LUXE) with a Buy and raises the price target from $12 to $13.
Economy · News reference
Dow Tumbles Over 600 Points as Fed Raises Rates: Investor Sentiment Weakens, Greed Index Remains in ‘Fear’ Zone
Market fear deepened as CNN’s index fell to 26; stocks mostly declined after the Fed’s rate hike, with the Dow dropping 631 points.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
JP Morgan Maintains Neutral on LuxExperience, Raises Price Target to $10
JP Morgan analyst Matthew Boss maintains LuxExperience (NYSE:LUXE) with a Neutral and raises the price target from $9 to $10.
Crude Oil Down Over 3%; US Business Inventories Surge In July
U.S. stocks mixed: Dow slipped 0.1%, Nasdaq rose 0.7%, S&P 0.3%; tech led gains, energy fell, while oil dropped 3.2%.
DataMEDS AI Enters Settlement Agreement On Sept 11, 2026; Expects To Extinguish $19M In Liability From Agreement
On September 11, 2026, DataMEDS AI, Inc. (the "Company") entered into a settlement agreement and release (the "Agreement") with Brian Norton, individually and as Seller Representative ("Norton"),
8-K filing — DataMeds AI, Inc. (MEDS)
Filed: 2026-09-17 AccNo: 0001493152-26-043169 Size: 198 KB Item 8.01: Other Events
DataMeds AI Shares Halted On Circuit Breaker To The Downside, Stock Now Down -4.61%